U.S. stock futures were lower this morning, with the Dow futures falling around 0.4% on Thursday.

Shares of Applied Digital Corporation (NASDAQ:APLD) fell sharply in pre-market trading following third-quarter results.

Applied Digital posted third-quarter revenue of $126.6 million, beating analyst estimates of $76.56 million, according to Benzinga Pro. The digital infrastructure provider reported adjusted earnings of nine cents per share for the quarter, beating estimates for a loss of 10 cents per share.

Applied Digital shares dipped 6.1% to $26.11 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• The Metals Royalty Company Inc. (NASDAQ:TMCR) fell 11.5% to $12.35 in pre-market trading after declining 7% on Wednesday.
• Simply Good Foods Co (NASDAQ:SMPL) dropped 9.8% to $13.00 in pre-market trading following second-quarter results.
• Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) fell 8.4% to $3.22 in pre-market trading. Biodexa Pharmaceuticals recently announced a partnership with Syngene International for the manufacture of both MTX240 active pharmaceutical ingredient and dosage form.
• Fulcrum Therapeutics, Inc. (NASDAQ:FULC) declined 6.2% to $7.41 in pre-market trading.
• LG Display Co., Ltd. (NYSE:LPL) dipped 5.6% to $4.06 in pre-market trading after gaining 9% on Wednesday.
• Grifols, S.A. (NASDAQ:GRFS) fell 4.4% to $8.02 in pre-market trading.
• Ascentage Pharma Group Internatinl – ADR (NASDAQ:AAPG) fell 4.3% to $25.42 in pre-market trading.
• Aspen Aerogels Inc (NYSE:ASPN) declined 4% to $3.56 in pre-market trading.
• Spyre Therapeutics Inc (NASDAQ:SYRE) fell 3.8% to $50.02 in pre-market trading.
• Nautilus Biotechnology Inc (NASDAQ:NAUT) slipped 3.2% to $3.03 in pre-market trading.
• Mitsubishi UFJ Financial Group Inc (NYSE:MUFG) fell 3.1% to $17.86 in pre-market trading.
• Mizuho Financial Group Inc (NYSE:MFG) shares declined 3.1% to $8.53 in pre-market trading after gaining around 7% on Wednesday.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.